These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 5723186)
21. Cholinergic mechanisms and alterations in behavioral suppression as factors producing time-dependent changes in avoidance performance. Anisman H J Comp Physiol Psychol; 1973 Jun; 83(3):465-77. PubMed ID: 4715307 [No Abstract] [Full Text] [Related]
22. Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine. Bohdanecký Z; Jarvik ME Int J Neuropharmacol; 1967 May; 6(3):217-22. PubMed ID: 6037526 [No Abstract] [Full Text] [Related]
23. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Matsuoka N; Maeda N; Yamaguchi I; Satoh M Brain Res; 1994 Apr; 642(1-2):11-9. PubMed ID: 7913390 [TBL] [Abstract][Full Text] [Related]
24. Role of cholinergic and monoaminergic brain systems in dissociated learning. Arkhipov VI; Azarashvili AA Neurosci Behav Physiol; 1981; 11(3):226-9. PubMed ID: 6120480 [No Abstract] [Full Text] [Related]
25. The effects of physostigmine on the response characteristics of the cat visual evoked potential. Rubboli G; Arakawa K; Celesia GG; Peachey NS; Tomoda H Doc Ophthalmol; 1993; 84(3):257-65. PubMed ID: 8119105 [TBL] [Abstract][Full Text] [Related]
26. EEG patterns during the behavioural desensitization to scopolamine in rats. Florio V; Bignami G; Longo VG Int J Neuropharmacol; 1969 Sep; 8(5):405-11. PubMed ID: 5344486 [No Abstract] [Full Text] [Related]
27. An analysis of the facilitation of avoidance acquisition produced by d-amphetamine and scopolamine. Barrett RJ; Leith NJ; Ray OS Behav Biol; 1974 Jun; 11(2):189-203. PubMed ID: 4847521 [No Abstract] [Full Text] [Related]
28. Permanent facilitation of avoidance behavior by d-amphetamine and scopolamine. Barrett RJ; Leith NJ; Ray OS Psychopharmacologia; 1972; 25(4):321-31. PubMed ID: 5051145 [No Abstract] [Full Text] [Related]
29. Active avoidance behavior in guinea pigs: effects of physostigmine and scopolamine. Philippens IH; Melchers BP; Wolthuis OL Pharmacol Biochem Behav; 1992 Jun; 42(2):285-9. PubMed ID: 1631181 [TBL] [Abstract][Full Text] [Related]
30. Disruptive effects of epinephrine on active avoidance behavior: alteration by scopolamine and d-amphetamine. Remington G; Anisman H Pharmacol Biochem Behav; 1974 May; 2(3):427-30. PubMed ID: 4837911 [No Abstract] [Full Text] [Related]
31. Effects of scopolamine and D-amphetamine on one-way, shuttle and inhibitory avoidance: a diallel analysis in mice. Anisman H Pharmacol Biochem Behav; 1975; 3(6):1037-42. PubMed ID: 1223892 [TBL] [Abstract][Full Text] [Related]
32. The cholinergic system, amnesia and memory. Lewis DJ; Bregman NJ Physiol Behav; 1972 Mar; 8(3):511-4. PubMed ID: 5064483 [No Abstract] [Full Text] [Related]
33. Effects of antimuscarinic cholinergic drugs injected systemically or into the hippocampo-entorhinal area upon passive avoidance learning in young rats. Blozovski D; Hennocq N Psychopharmacology (Berl); 1982; 76(4):351-8. PubMed ID: 6812110 [TBL] [Abstract][Full Text] [Related]
34. Effects of hippocampal microinjections of D-amphetamine and scopolamine on active avoidance behavior in rats. Leith MJ; Barrett RJ J Comp Physiol Psychol; 1975 Jan; 88(1):285-99. PubMed ID: 1120804 [TBL] [Abstract][Full Text] [Related]
35. Comparative effects of physostigmine and neostigmine on acquisition and performance of a conditioned avoidance behavior in the rat. Rosecrans JA; Domino EF Pharmacol Biochem Behav; 1974; 2(1):67-72. PubMed ID: 4828484 [No Abstract] [Full Text] [Related]
37. Methodological problems in evaluating the role of cholinergic mechanisms in behavior. Weiss B; Heller A Fed Proc; 1969; 28(1):135-46. PubMed ID: 4974735 [No Abstract] [Full Text] [Related]
38. Differential attenuation by atropine and d-amphetamine on hyperactivity: possible clinical implications. Egbe PC; Wray SR Psychopharmacology (Berl); 1977 Aug; 54(1):25-30. PubMed ID: 410057 [TBL] [Abstract][Full Text] [Related]